Viewpoints on Innovation

Innovation Measures #5 - Forecast Degradation

Governance Consumer Goods High Technology Industrial Manufacturing Medical Device Pharmaceutical Healthcare Chief Innovation Officer

The metrics we have been discussing over the past couple of weeks were designed to be either predictive or to measure historical effectiveness of investments in innovation. Today we look at tracking a set of numbers that should help us improve the ability of the organization to predict the financial impact of individual initiatives. The constant and consistent degradation of forecast revenue and margin as a new concept works its way through the development cycle and into market is a common problem.

You know how this works. The $100 million idea becomes a $75 million concept that turns into a $50 million product just prior to launch. We then end up with $25 million in first year revenues and that is deemed insufficient to warrant further investment and the product gets pulled from the market. This degradation is not just a function of a better understanding of the market opportunity. The financial forecasts should become more accurate as we learn more, not just smaller.

It is not surprising that our forecasts prove to be wrong when we are estimating financials at the early stages of development. We are dealing with assumptions built upon assumptions about events that will happen months or years in the future. If the idea is truly innovative then there are no benchmarks or analogs to use as comparisons. That makes the job even harder. What is surprising is that we are almost always wrong on the upside. The bias to overestimate financial results is pervasive and persistent.

We can tackle this problem by tracking risk-adjusted forecasts at each stage of development and comparing them to actual results in market. Combine this disciplined measurement system with a process of post-launch review that forces the team to identify the sources of variance in the original forecast. This will create a learning organization that gets better at predicting the future.

Read More

Innovation Measures #1 - Pipeline ECV

Innovation Measures #2 - Development Cycle Time

Innovation Measures #3 - R&D Growth Effectiveness

Innovation Measures #4 - R&D Effectiveness Index

Innovation Measures #5 - Forecast Degradation

Innovation Measures #6 - Resource Productivity

Innovation Measures #7 - Innovation Vitality Index

Innovation Measures #8 - Incremental Sales

Originally published at

Originally published on February 13th, 2015

What's your view? Add your question or comment

Topics: Bill Poston, Chief Innovation Officer, Development Cycle, Effectiveness of Innovation, Financial Impact, Innovation, Investment in Innovation

About the Author

Bill Poston

Bill Poston

For the past 30 years, Bill has helped executives in technology-driven industries transform their competencies to deliver results. He is a highly regarded consultant, speaker, and writer on the topics of innovation strategy, product development, portfolio management, technology commercialization, and the software systems that enable innovation. Keep up with Bill's latest research and thoughts on innovation and the rising role of the Chief Innovation Officer at
More Viewpoints by Bill Poston

What's Your View?

comments powered by Disqus

Don't miss future posts.
Get Viewpoints Digests delivered right to your inbox.

Subscribe Now Leave me alone